Marc Lafonte, MD
Surgical Critical Care · New Brunswick, NJNPI 1043535180
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by La Jolla Pharmaceutical Company at 42.5% of the total. Reporting peaked in 2022 at $636 and has fallen 51.8% since, to $306 in 2023.
Across 12 payments — averaging $93.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- La Jolla Pharmaceutical Company$477
- AstraZeneca$240
- CSL Behring$238
- Chiesi USA, Inc.$110
- Abiomed$42
- KCI USA, Inc.$15
What the payments were for
- Food & beverage$1,122100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| La Jolla Pharmaceutical Company | 5 | $477 |
| AstraZeneca(2 entities) | 2 | $240 |
| CSL Behring | 2 | $238 |
| Chiesi USA, Inc. | 1 | $110 |
| Abiomed | 1 | $42 |
| KCI USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,122 in reported general payments places this provider in the 60th percentile of 45 surgical critical care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical critical care in New Brunswick
- Hesham AhmedNew Brunswick$164K
- Emad Nourollah-ZadehNew Brunswick$4K
- Anuradha KarNew Brunswick$3K
- Rachel ChoronNew Brunswick$1K
- Arianne RaynerNew Brunswick$386
- Daniel WhitleyNew Brunswick$353
- Andrew BoyarskyNew Brunswick$89
- Gustavo BauzaNew Brunswick$47
- Maurizio MigliettaTeaneck$131K
- Ju Lin WangCamden$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.